What does the overall research say about PFAS exposure and lower birth weight in newborns?

What's actually in it

PFAS cross the placenta throughout pregnancy. They disrupt thyroid hormones, growth factors, and insulin signaling, all of which regulate how much weight a fetus gains, especially in the third trimester. The concern is that PFAS exposure during pregnancy consistently appears in study after study across different countries and populations.

Birth weight is a key indicator of newborn health. Lower birth weight is associated with higher infant mortality risk, respiratory problems, and long-term metabolic disease risk.

What the research says

A 2026 systematic review and meta-analysis of birth weight and prenatal PFAS exposure pooled data from dozens of studies across multiple countries and found a consistent, statistically significant inverse relationship: higher maternal PFAS levels were associated with lower birth weight. The meta-analysis also found that certain PFAS compounds (PFOA, PFOS, and several others) showed the strongest associations.

This is the kind of high-quality evidence that drives clinical recommendations. A single study can be questioned; a meta-analysis of many studies from different populations with consistent results provides much stronger evidence for a causal relationship.

The most effective way to reduce prenatal PFAS exposure is to change household sources before pregnancy: switch from nonstick to cast iron or stainless steel cookware, filter drinking water, and avoid PFAS-treated food packaging.